TickerFacts.

20/20 Biolabs, Inc. (AIDX): Cash & Equivalents

Annual figures by period end, from SEC filings.

$1.03M
As of 2025-12-31
$4.55M
As of 2026-06-30
$1.78M2024-12-31: $1.78M2025-12-31: $1.03M$1.03M
2024-12-31 Cash & Equivalents (USD) 2025-12-31
Period endedCash & EquivalentsChange YoYSource filing
2025-12-31$1.03M-42.5%2026-03-31, Balance as of period end
2024-12-31$1.78Mn/a2026-03-31, Balance as of period end

Cash & Equivalents at similar companies

Companies with the same SEC industry code (Services-Testing Laboratories), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCash & EquivalentsChange YoY
20/20 Biolabs, Inc. (AIDX)2025-12-31$1.03M-42.5%
NeoGenomics Inc (NEO)2025-12-31$159.62M-56.5%
UL Solutions Inc. (ULS)2025-12-31$295.00M-1.0%

Compare AIDX, NEO, ULS side by side · Screen every company in Services-Testing Laboratories ↗